Agilent Restructures, Laying off 450; Q2 Revenues Flat | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies announced after the close of the market on Tuesday a restructuring program expected to reduce its headcount by about 450 employees and save the company $50 million annually in operating expenses.

The Santa Clara, Calif.-based firm also reported that revenues were flat year over year in its fiscal second quarter and that its board approved an additional $500 million to its existing share buy-back program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.